Video

Dr Yousuf Zafar Explains How Financial Toxicity Impacts Cancer Patients

The term financial toxicity is relatively new and is being used to draw parallels between the physical toxicities of chemotherapy and the cost-related burdens cancer patients face.

Insured cancer patients who are experiencing more and more out-of-pocket costs are finding themselves having to cut back on basics like food and clothing, Yousuf Zafar, MD, associate professor of medicine at the Duke Cancer Institute, said in December at the 2014 Annual Meeting of the American Society of Hematology.

The term financial toxicity is relatively new and it is used to draw parallels between the physical toxicities of chemotherapy and the cost-related burdens cancer patients feel, he explained.

“There is a direct and concrete impact of financial toxicity on the quality of cancer care,” Dr Zafar added.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Carrie Kitko
Merrill H. Stewart, MD
Nicolas Ferreyros, managing director, Community Oncology Alliance
Dr Ibrahim Aldoss
Jody Agena, PharmD, MBA, director of pharamcy operations, Virginia Cancer Specialists
Rachel Rohaidy, MD
Mansi Shah, MD
Miriam Freimer, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo